Optimizing weight control in diabetes: antidiabetic drug selection

QR Code

Optimizing weight control in diabetes: antidiabetic drug selection

S Kalra1, B Kalra1, AG Unnikrishnan2, N Agrawal3, S Kumar41Bharti Hospital, Karnal; 2Amrita Institute of Medical Science, Kochi; 3Medical College, Gwalior; 4Excel Life Sciences, Noida, IndiaDate of preparation: 18th August 2010Conflict of interest: SK has received speaker fees from Novo Nordisk, san...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Kalra S
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	weight control diabetes antidiabetic drugs Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/f156546818cd4b9fb6e2e02aca6296a7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Optimizing weight control in diabetes: antidiabetic drug selection
par: S Kalra, et autres
Publié: (2010)

In vivo Antidiabetic Activity Evaluation of Aqueous and 80% Methanolic Extracts of Leaves of Thymus schimperi (Lamiaceae) in Alloxan-induced Diabetic Mice
par: Melesie Taye G, et autres
Publié: (2020)

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
par: Levin PA, et autres
Publié: (2017)

SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients
par: Scheen AJ
Publié: (2020)

Practical combination therapy based on pathophysiology of type 2 diabetes
par: Levin PA
Publié: (2016)

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
par: Pscherer S, et autres
Publié: (2016)

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
par: Sikirica MV, et autres
Publié: (2017)

Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes
par: Wake AD
Publié: (2020)

Antihyperglycemic Activity of TLC Isolates from the Leaves of Aloe megalacantha Baker in Streptozotocin-Induced Diabetic Mice
par: Araya TY, et autres
Publié: (2021)

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data
par: Kugler AJ, et autres
Publié: (2018)

Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia
par: Fasil A, et autres
Publié: (2018)

Effect of Pleurotus fossulatus Aqueous Extract on Biochemical Properties of Liver and Kidney in Streptozotocin-Induced Diabetic Rat
par: Dubey S, et autres
Publié: (2020)

Drug-Related Problems and Their Predictors Among Patients with Diabetes Attending the Ambulatory Clinic of Gebre Tsadik Shawo General Hospital, Southwest Ethiopia
par: Mechessa DF, et autres
Publié: (2020)

Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice
par: Talba T, et autres
Publié: (2011)

Lifestyle Intervention for Weight Loss: a group-based program for Emiratis in Ajman, United Arab Emirates
par: Sadiya A, et autres
Publié: (2016)

Antidiabetic and Anti-hyperlipidemic Effects of the Crude Hydromethanol Extract of Hagenia abyssinica (Rosaceae) Leaves in Streptozotocin-Induced Diabetic Mice
par: Kifle ZD, et autres
Publié: (2020)

Association Between Severity of Diabetic Neuropathy and Success in Weight Loss During Hospitalization Among Japanese Patients with Type 2 Diabetes: A Retrospective Observational Study
par: Nakanishi S, et autres
Publié: (2020)

Determinants of Diabetic Complication Among Adult Diabetic Patients in Debre Markos Referral Hospital, Northwest Ethiopia, 2018: Unmatched Case Control Study
par: Kidanie BB, et autres
Publié: (2020)

Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice
par: Jarrar YB, et autres
Publié: (2018)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
par: Wilke T, et autres
Publié: (2019)

Evaluation of Antidiabetic Effect of Ethanolic Leaves Extract of Becium grandiflorum Lam. (Lamiaceae) in Streptozotocin-Induced Diabetic Mice
par: Gebremeskel L, et autres
Publié: (2020)

Smartphone applications to aid weight loss and management: current perspectives
par: Sutton EF, et autres
Publié: (2016)

Antidiabetic and Nephroprotective Effects of Polysaccharide Extract from the Seaweed Caulerpa racemosa in High Fructose-Streptozotocin Induced Diabetic Nephropathy
par: Cao M, et autres
Publié: (2021)

Glycemic Control, Diabetes Complications and Their Determinants Among Ambulatory Diabetes Mellitus Patients in Southwest Ethiopia: A Prospective Cross-Sectional Study
par: YimamAhmed M, et autres
Publié: (2020)

When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs
par: Volpe S, et autres
Publié: (2021)

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
par: Kapoor S
Publié: (2012)

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population
par: Funch D, et autres
Publié: (2021)

The Prevalence and Control of Type 2 Diabetes Mellitus in Residents of a Rural Town, Shandong Province, China
par: Wei M, et autres
Publié: (2021)

Prevalence of diabetes and obesity in association with prematurity and growth restriction
par: Kopec G, et autres
Publié: (2017)

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
par: Bradley Curtis, et autres
Publié: (2008)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
par: Via MA
Publié: (2010)

Tackling obesity: new therapeutic agents for assisted weight loss
par: McFarlane S
Publié: (2010)

Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds
par: Nie X, et autres
Publié: (2020)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
par: Le Floch J
Publié: (2010)

Predictors of weight loss and maintenance in patients treated with antiobesity drugs
par: Guaraldi F, et autres
Publié: (2011)

Improvement in Cardiometabolic Risk Factors During Smoking Cessation Treatment in Patients with Type 2 Diabetes: A Retrospective Cohort Study
par: Chen HJ, et autres
Publié: (2021)

Weight loss medications in Canada – a new frontier or a repeat of past mistakes?
par: Wharton S, et autres
Publié: (2017)

The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia
par: Alzaheb RA, et autres
Publié: (2018)

Clinical effectiveness of quercetin supplementation in the management of weight loss: a pooled analysis of randomized controlled trials
par: Huang H, et autres
Publié: (2019)

Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs
par: Olga D. Ostroumova, et autres
Publié: (2018)